Skip to main content
Premium Trial:

Request an Annual Quote

Lion Launches Gene Expression Tools for Rat

NEW YORK, March 1 – Lion Bioscience launched Thursday a version of its gene expression tools, arrayTAG and arrayBASE, for rat.

ArrayTAG, which consists of 10,000 cDNA clones is linked to the company’s annotation database, arrayBASE, which offers information about each clone. ArrayBASE is also linked to Lion’s analysis software, arraySCOUT. 

In January Lion launched a similar system for mouse.

“Our arrayTAG and arrayBASE are important modules within our integrated expression profiling solution, which spans genomic content, data interpretation, target identification, and validation,” Jan Mous, Lion’s chief scientific officer, said in a statement. “Through this integrated information offering, Lion aims to improve efficiency and effectiveness of drug development for life science companies."

Lion of Heidelberg, Germany said it expects to release more non-redundant sets of arrayTAG of mouse and rat, as well as for other animal species, in the near future.

The company did not say how many customers it had for its microarray tools or disclose their price. A spokesperson could not immediately be reached for comment.

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.